MarketPulse
C

$CTXR

2 articles found
2 positive
0 negative
0 neutral
BenzingaBenzinga··Prnewswire

Citius Pharma Posts Inaugural Revenue on LYMPHIR™ Commercial Launch

Citius Pharma reports first revenue of $3.9M from LYMPHIR™ launch, raises $20.9M to support growth and advance pipeline candidates.
CTXRCTORorphan drugimmunotherapy
BenzingaBenzinga··Prnewswire

Citius Oncology Posts Maiden Revenue of $3.9M From LYMPHIR Launch

Citius Oncology reports maiden revenue of $3.9M from LYMPHIR immunotherapy launch in December 2025, marking transition to commercial-stage biopharmaceutical company.
CTXRCTORnet lossFDA approval